Follow
Christopher M  Reilly
Christopher M Reilly
Virginia tech, VCOM, Via College of Osteopathic Medicine
Verified email at vt.edu
Title
Cited by
Cited by
Year
Anti‐inflammatory properties of cerium oxide nanoparticles
SM Hirst, AS Karakoti, RD Tyler, N Sriranganathan, S Seal, CM Reilly
Small 5 (24), 2848-2856, 2009
7922009
Leaky gut as a danger signal for autoimmune diseases
Q Mu, J Kirby, CM Reilly, XM Luo
Frontiers in immunology 8, 269575, 2017
5732017
Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse
N Mishra, CM Reilly, DR Brown, P Ruiz, GS Gilkeson
The Journal of clinical investigation 111 (4), 539-552, 2003
4732003
Bio‐distribution and in vivo antioxidant effects of cerium oxide nanoparticles in mice
SM Hirst, A Karakoti, S Singh, W Self, R Tyler, S Seal, CM Reilly
Environmental toxicology 28 (2), 107-118, 2013
3752013
Control of lupus nephritis by changes of gut microbiota
Q Mu, H Zhang, X Liao, K Lin, H Liu, MR Edwards, SA Ahmed, R Yuan, ...
Microbiome 5, 1-12, 2017
2952017
Nanoceria: a rare-earth nanoparticle as a novel anti-angiogenic therapeutic agent in ovarian cancer
S Giri, A Karakoti, RP Graham, JL Maguire, CM Reilly, S Seal, R Rattan, ...
PloS one 8 (1), e54578, 2013
2702013
Combined cytotoxic and anti-invasive properties of redox-active nanoparticles in tumor–stroma interactions
L Alili, M Sack, AS Karakoti, S Teuber, K Puschmann, SM Hirst, CM Reilly, ...
Biomaterials 32 (11), 2918-2929, 2011
2702011
Gut microbiota in human systemic lupus erythematosus and a mouse model of lupus
XM Luo, MR Edwards, Q Mu, Y Yu, MD Vieson, CM Reilly, SA Ahmed, ...
Applied and environmental microbiology 84 (4), e02288-17, 2018
2602018
Hematopoietic origin of glomerular mesangial cells
M Masuya, CJ Drake, PA Fleming, CM Reilly, H Zeng, WD Hill, ...
Blood, The Journal of the American Society of Hematology 101 (6), 2215-2218, 2003
2402003
Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid
CM Reilly, N Mishra, JM Miller, D Joshi, P Ruiz, VM Richon, PA Marks, ...
The Journal of Immunology 173 (6), 4171-4178, 2004
1772004
Androgens and penile erection: a review
TM Mills, CM Reilly, RW Lewis
Journal of Andrology 17 (6), 633-638, 1996
1721996
Androgenic regulation of NO availability in rat penile erection
CM REILLY, P ZAMORANO, VS STOPPER, TM MILLS
Journal of andrology 18 (2), 110-115, 1997
1691997
Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice
H Sekine, CM Reilly, ID Molano, G Garnier, A Circolo, P Ruiz, VM Holers, ...
The Journal of Immunology 166 (10), 6444-6451, 2001
1612001
Androgens modulate the α‐adrenergic responsiveness of vascular smooth muscle in the corpus cavernosum
CM REILLY, VS STOPPER, TM MILLS
Journal of andrology 18 (1), 26-31, 1997
1261997
Activation of AMPK inhibits inflammation in MRL/lpr mouse mesangial cells
A Peairs, A Radjavi, S Davis, L Li, A Ahmed, S Giri, CM Reilly
Clinical & Experimental Immunology 156 (3), 542-551, 2009
1252009
Production with Lupus Disease Activity
G Gilkeson, C Cannon, J Oates, C Reilly, D Goldman, M Petri
The Journal of Rheumatology 26, 2, 1999
1211999
The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice
CM Reilly, M Thomas, R Gogal Jr, S Olgun, A Santo, R Sodhi, ET Samy, ...
Journal of autoimmunity 31 (2), 123-130, 2008
1122008
Antibiotics ameliorate lupus-like symptoms in mice
Q Mu, VJ Tavella, JL Kirby, TE Cecere, M Chung, J Lee, S Li, SA Ahmed, ...
Scientific reports 7 (1), 13675, 2017
1092017
Inhibition of mesangial cell nitric oxide in MRL/lpr mice by prostaglandin J2 and proliferator activation receptor-γ agonists
CM Reilly, JC Oates, JA Cook, JD Morrow, PV Halushka, GS Gilkeson
The Journal of Immunology 164 (3), 1498-1504, 2000
1072000
Protonated nanoparticle surface governing ligand tethering and cellular targeting
A Vincent, S Babu, E Heckert, J Dowding, SM Hirst, TM Inerbaev, WT Self, ...
ACS nano 3 (5), 1203-1211, 2009
1042009
The system can't perform the operation now. Try again later.
Articles 1–20